CNCE

Concert Pharmaceuticals, Inc.

Delisted

CNCE was delisted on the 3rd of March, 2023.

51 hedge funds and large institutions have $82.6M invested in Concert Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$15.2M
2 +$6.74M
3 +$4.14M
4
EI
EAM Investors
California
+$3.82M
5
GTC
Ghost Tree Capital
New York
+$3.54M

Top Sellers

1 -$11.6M
2 -$6.24M
3 -$5.15M
4
BG
BlackRock Group
United Kingdom
-$1.37M
5
Citigroup
Citigroup
New York
-$1.13M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$329K
27
$304K
28
$296K
29
$286K
30
$256K
31
$237K
32
$230K
33
$189K
34
$180K
35
$174K
36
$173K
37
$170K
38
$166K
39
$150K
40
$128K
41
$41K
42
$40K
43
$39K
44
$38K
45
$32K
46
$19K
47
$16K
48
$14K
49
$13K
50
$1K